Skip to content
Search

Latest Stories

Britain refuses to sign WHO pandemic accord over vaccine sharing

Britain refuses to sign WHO pandemic accord over vaccine sharing

As per the pandemic accord, 20 % of tests, treatments and vaccines to be shared among poorer countries 

Britain has declined to sign the World Health Organization's (WHO) proposed pandemic accord, citing concerns over the redistribution of vaccines, as reported by The Telegraph on Tuesday.

The accord aims to ensure fair distribution of resources during global health crises, including reserving 20 per cent of tests, treatments, and vaccines for distribution in poorer nations.


According to media reports the Department of Health and Social Care stated that they would only support the adoption of the accord if it aligns with the national interest and respects sovereignty.

However, a DHSC spokesperson refrained from detailing the specific proposals within the accord, emphasising that no agreements had been reached yet.

The WHO has not yet responded to requests for comment on this matter.

The proposed pact, alongside updates to existing pandemic management protocols, seeks to fortify the global response to emerging pathogens following the devastating impact of the COVID-19 pandemic.

However, according to Reuters,  disagreements persist between affluent nations and developing countries regarding the equitable sharing of vaccines and treatments.

Negotiations on the accord are set to conclude on May 10, with plans for adoption during the WHO's upcoming annual assembly later this month.

WHO Director-General Tedros Adhanom Ghebreyesus urged countries to reach consensus within the deadline, emphasising the importance of collective action in combating future pandemics.

He called upon nations not fully in agreement with the text to refrain from obstructing consensus among the WHO's 194 member states.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less